NAD+ Augmentation in Obese Adults: Implications for Healthspan Extension — RetatrutideCompare

Sinclair Lab Research ·

Nicotinamide adenine dinucleotide (NAD+) augmentation through its precursor, β-nicotinamide mononucleotide, shows promise in improving health metrics in overweight or obese middle-aged and older adults. As NAD+ levels decline with age, this study investigates the safety and physiological effects of its supplementation, which may contribute to mitigating age-related diseases and promoting longevity.

What this study examined

This research evaluated the effects of NAD+ augmentation in a randomized controlled trial involving thirty overweight or obese adults aged 45 years and older. Participants were assigned in a 2:1 ratio to receive either two tablets of MIB-626, each containing 500 mg of β-nicotinamide mononucleotide, or a placebo, twice daily for a duration of 28 days. The primary outcomes assessed included safety, changes in NAD+ levels and its metabolites, body weight, insulin sensitivity, blood pressure, lipid profiles, and physical performance metrics.

Why this matters for longevity research

The decline in NAD+ levels with aging has been linked to various age-related diseases, making NAD+ augmentation a compelling area of study in longevity research. By targeting NAD+ levels, researchers aim to understand its role in enhancing healthspan—the period of life spent in good health—potentially delaying the onset of age-related conditions. This study provides preliminary evidence supporting the safety and physiological benefits of NAD+ supplementation, which could lead to larger trials aimed at improving cardiometabolic outcomes in older adults.

Key findings

  • NAD+ levels and its metabolites significantly increased in the MIB-626 group compared to placebo.
  • Body weight decreased by an average of 1.9 kg in the MIB-626 group.
  • Diastolic blood pressure reduced by 7.01 mmHg in the treatment group.
  • Total cholesterol levels decreased by 26.89 mg/dL in the MIB-626 group.
  • Low-density lipoprotein (LDL) cholesterol levels dropped by 18.73 mg/dL in the treatment group.
  • Adverse events were similar between the MIB-626 and placebo groups, indicating safety.
  • Changes in muscle strength, aerobic capacity, and insulin sensitivity did not differ significantly between groups.

The science behind it

NAD+ is a crucial coenzyme involved in various metabolic processes, including energy production and DNA repair. It plays a vital role in activating sirtuins, a family of proteins linked to longevity and cellular health. The sirtuin pathway is associated with the regulation of metabolic processes, stress responses, and aging. By enhancing NAD+ levels, researchers aim to activate sirtuins, potentially improving healthspan and delaying age-related decline. The study's findings suggest that NAD+ augmentation may influence key metabolic parameters, including lipid profiles and blood pressure, which are critical for maintaining overall health as individuals age.

How it fits into the longevity field

This study aligns with the broader research on NAD+ and its role in aging. Previous studies have indicated that NAD+ supplementation can improve metabolic health and promote longevity. Adjacent interventions, such as caloric restriction and exercise, also enhance NAD+ levels and activate sirtuins, further supporting the idea that boosting NAD+ could be a viable strategy for extending healthspan. The findings from this study contribute to the growing body of literature advocating for NAD+ augmentation as a potential therapeutic approach in aging research.

Practical takeaways

Researchers and informed readers should note that while this study demonstrates the safety and potential benefits of NAD+ augmentation in improving certain health metrics, further research is needed to establish its efficacy fully. Larger trials are warranted to explore the long-term effects of NAD+ supplementation on healthspan and to understand the mechanisms underlying its benefits. As the field of longevity research evolves, understanding the role of NAD+ in age-related diseases will be essential for developing effective interventions.

FAQ

What is NAD+ and why is it important?

NAD+ is a coenzyme essential for energy metabolism and cellular processes. Its levels decline with age, contributing to age-related diseases.

How does NAD+ supplementation work?

NAD+ supplementation, particularly through precursors like β-nicotinamide mononucleotide, aims to boost NAD+ levels, potentially improving metabolic health and activating longevity-related pathways.

What are the implications of this study for older adults?

The study suggests that NAD+ augmentation may safely improve certain health metrics in older adults, indicating a potential avenue for enhancing healthspan.

Source: PubMed · J Clin Endocrinol Metab · published 2023-07-14.